Dernières nouvelles pour GE HealthCare Techs (NASDAQ:GEHC) Stock

GE HealthCare Techs

GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).

GE HealthCare Technologies Inc. - Common Stock

GE HealthCare Technologies Inc

<p>JP Morgan  analyst John Stansel   maintains Molina Healthcare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOH#NYSE">MOH</a>) with a Neutral and lowers the price target from $272 to $184.</p>


News

Price Target

Analyst Ratings

JP Morgan Maintains Neutral on Molina Healthcare, Lowers Price Target to $184

<p><a href="https://zoox.com/journal/zoox-official-autonomous-ride-hail-partner-area15-las-vegas/">https://zoox.com/journal/zoox-official-autonomous-ride-hail-partner-area15-las-vegas/</a></p>


General

AMZN

'Zoox Is The Official Autonomous Ride-Hail Partner Of Area15 In Las Vegas'

Trading Ideas

RCON

Recon Technology Shares Halted On Circuit Breaker To The Upside, Stock Now Up 96.8%

<p>JP Morgan  analyst John Stansel   maintains Centene (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNC#NYSE">CNC</a>) with a Neutral and lowers the price target from $48 to $30.</p>


JP Morgan Maintains Neutral on Centene, Lowers Price Target to $30

<p>JP Morgan  analyst Eli Jossen   assumes Aris Water Solutions (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARIS#NYSE">ARIS</a>) with a Neutral rating and lowers Price Target of $25.</p>


Initiation

ARIS

JP Morgan Assumes Aris Water Solutions at Neutral, Lowers Price Target of $25

<p><a href="https://www.marijuanamoment.net/massachusetts-psychiatric-society-endorses-bill-to-decriminalize-psilocybin-possession/" title="https://www.marijuanamoment.net/massachusetts-psychiatric-society-endorses-bill-to-decriminalize-psilocybin-possession/">https://www.marijuanamoment.net/massachusetts-psychiatric-society-endorses-bill-to-decriminalize-psilocybin-possession/</a></p>


Biotech

ATAI

CMPS

CYBN

DRUG

ENVB

MNMD

'Massachusetts Psychiatric Society Endorses Bill To Decriminalize Psilocybin Possession' - Marijuana Moment

<p><strong>Microsoft Corporation</strong> (NASSAQ:MSFT) shares are in the spotlight Tuesday ahead of fourth quarter earnings. Here&#8217;s what you <a href="https://www.benzinga.com/node/46689600">need to know</a>.</p>
<p><strong>What To Know:</strong> Analysts estimate earnings per share of $3.37 and revenue of $73.80 billion. The company reported third-quarter earnings of $3.46 per share, topping the $3.22 estimate, and revenue of $70.07 billion, beating the $66.43 billion estimate.</p>
<p>Microsoft has a strong track record of beating both earnings per share and revenue guidance. </p>
<p><strong>Analyst Changes: </strong>Ahead of the earnings report, multiple analysts issued price target adjustments.</p>
<ul class="wp-block-list">
<li>Raymond James analyst <strong>Andrew Marok</strong> maintained an Outperform rating on Microsoft and raised the price target from $490 to $570.</li>
<li>Stifel analyst <strong>Brad Reback </strong>maintained a Buy rating on Microsoft and raised the price target from $500 to $550.</li>
<li>Wedbush analyst <strong>Daniel Ives</strong> reiterated an Outperform rating on Microsoft and maintained a  $600 price target.</li>
<li>Evercore ISI Group analyst <strong>Kirk Materne</strong> maintained an Outperform rating on Microsoft and raised the price target from $515 to $545.</li>
<li>Loop Capital analyst <strong>Yun Kim</strong> maintained a Buy rating on  Microsoft and raised the price target from $550 to $600. </li>
</ul>
<p>The consensus estimate for Microsoft is $554.61, with the lowest price target at $475 and the highest price target at $613.</p>
<p>Microsoft is expected to report earnings on Wednesday after the market closes.</p>
<p><strong>Related Link: <a href="https://www.benzinga.com/markets/tech/25/07/46686037/nvidia-is-now-worth-twice-tesla-amd-palantir-and-intel-combined">Nvidia Is Now Worth Twice Tesla, AMD, Palantir, And Intel Combined</a></strong></p>
<p><strong>MSFT Price Action:</strong> At the time of writing, Microsoft shares are trading 0.32% higher at $514.09, according to data from Benzinga Pro.</p>
<p><em>Image via Shutterstock</em></p>


Movers

MSFT

What's Going On With Microsoft Stock Tuesday?

<p><strong>Western Digital</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WDC#NASDAQ">WDC</a>) is set to give its latest quarterly earnings report on Wednesday, 2025-07-30. Here's what investors need to know before the announcement.</p>
<p>Analysts estimate that Western Digital will report an <strong>earnings per share</strong> (EPS) of $1.43. </p>
<p>Western Digital bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Historical Earnings Performance</h3>
<p>During the last quarter, the company reported an EPS beat by $0.23, leading to a 0.21% increase in the share price on the subsequent day.</p>
<p>Here's a look at Western Digital's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2025</strong></th>
<th><strong>Q2 2025</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.13</td>
<td>1.82</td>
<td>1.71</td>
<td>1.15</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.36</td>
<td>1.77</td>
<td>1.78</td>
<td>1.44</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>0.0%</td>
<td>5.0%</td>
<td>5.0%</td>
<td>-10.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1753804988_0.png" alt="eps graph" /></p>
<h3>Tracking Western Digital's Stock Performance</h3>
<p>Shares of Western Digital were trading at $68.985 as of July 28. Over the last 52-week period, shares are up 38.62%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<h3>Analysts' Perspectives on Western Digital</h3>
<p>For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Western Digital.</p>
<p>Analysts have given Western Digital a total of 18 ratings, with the consensus rating being Outperform. The average one-year price target is $70.06, indicating a potential 1.56% upside.</p>
<h3>Comparing Ratings with Competitors</h3>
<p>In this comparison, we explore the analyst ratings and average 1-year price targets of Hewlett Packard, NetApp and Pure Storage, three prominent industry players, offering insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Neutral trajectory for Hewlett Packard, with an average 1-year price target of $23.31, suggesting a potential 66.21% downside.</li>
<li>Analysts currently favor an Neutral trajectory for NetApp, with an average 1-year price target of $112.6, suggesting a potential 63.22% upside.</li>
<li>Analysts currently favor an Buy trajectory for Pure Storage, with an average 1-year price target of $67.5, suggesting a potential 2.15% downside.</li>
</ul>
<h3>Comprehensive Peer Analysis Summary</h3>
<p>Within the peer analysis summary, vital metrics for Hewlett Packard, NetApp and Pure Storage are presented, shedding light on their respective standings within the industry and offering valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Western Digital</td>
<td>Outperform</td>
<td>30.94%</td>
<td>$912M</td>
<td>5.86%</td>
</tr>
<tr>
<td>Hewlett Packard</td>
<td>Neutral</td>
<td>5.87%</td>
<td>$2.17B</td>
<td>-4.40%</td>
</tr>
<tr>
<td>NetApp</td>
<td>Neutral</td>
<td>3.84%</td>
<td>$1.19B</td>
<td>33.42%</td>
</tr>
<tr>
<td>Pure Storage</td>
<td>Buy</td>
<td>12.26%</td>
<td>$536.15M</td>
<td>-1.10%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Western Digital ranks first in revenue growth among its peers. It ranks second in gross profit. It ranks third in return on equity.</p>
<h3>Delving into Western Digital's Background</h3>
<p>Western Digital is a leading, vertically integrated supplier of hard disk drives. The HDD market is a practical duopoly with, Western Digital and Seagate being the two largest players. Western Digital designs and manufacturers its HDDs, with much of the manufacturing and workforce located in Asia. The primary consumers of HDDs are data centers.</p>
<h3>Financial Milestones: Western Digital's Journey</h3>
<p><strong>Market Capitalization Analysis:</strong> The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.</p>
<p><strong>Revenue Growth:</strong> Western Digital's revenue growth over a period of 3 months has been noteworthy. As of 31 March, 2025, the company achieved a revenue growth rate of approximately <strong>30.94%</strong>. This indicates a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Information Technology sector.</p>
<p><strong>Net Margin:</strong> The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of <strong>22.1%,</strong> the company may need to address challenges in effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> Western Digital's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of <strong>5.86%,</strong> the company showcases efficient use of equity capital and strong financial health.</p>
<p><strong>Return on Assets (ROA):</strong> Western Digital's ROA excels beyond industry benchmarks, reaching <strong>2.42%</strong>. This signifies efficient management of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> Western Digital's debt-to-equity ratio stands notably higher than the industry average, reaching <strong>1.42</strong>. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.</p>
<p><a href="https://www.benzinga.com/quote/WDC/earnings"><strong>To track all earnings releases for Western Digital visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Earnings

What's Next: Western Digital's Earnings Preview

<p><strong>United Therapeutics</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UTHR#NASDAQ">UTHR</a>) is set to give its latest quarterly earnings report on Wednesday, 2025-07-30. Here's what investors need to know before the announcement.</p>
<p>Analysts estimate that United Therapeutics will report an <strong>earnings per share</strong> (EPS) of $6.87. </p>
<p>The announcement from United Therapeutics is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.</p>
<p>It's worth noting for new investors that guidance can be a key determinant of stock price movements.</p>
<h3>Overview of Past Earnings</h3>
<p>In the previous earnings release, the company beat EPS by $0.10, leading to a 3.05% drop in the share price the following trading session.</p>
<p>Here's a look at United Therapeutics's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>6.53</td>
<td>6.31</td>
<td>6.42</td>
<td>6.40</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>6.63</td>
<td>6.19</td>
<td>6.39</td>
<td>5.85</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-3.0%</td>
<td>1.0%</td>
<td>3.0%</td>
<td>5.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1753804978_0.png" alt="eps graph" /></p>
<h3>United Therapeutics Share Price Analysis</h3>
<p>Shares of United Therapeutics were trading at $298.14 as of July 28. Over the last 52-week period, shares are down 4.04%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. </p>
<h3>Analyst Opinions on United Therapeutics</h3>
<p>For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on United Therapeutics.</p>
<p>The consensus rating for United Therapeutics is Neutral, based on 9 analyst ratings. With an average one-year price target of $356.33, there's a potential 19.52% upside.</p>
<h3>Comparing Ratings with Competitors</h3>
<p>In this analysis, we delve into the analyst ratings and average 1-year price targets of Neurocrine Biosciences, Moderna and Incyte, three key industry players, offering insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Buy trajectory for Neurocrine Biosciences, with an average 1-year price target of $153.67, suggesting a potential 48.46% downside.</li>
<li>Analysts currently favor an Neutral trajectory for Moderna, with an average 1-year price target of $36.83, suggesting a potential 87.65% downside.</li>
<li>Analysts currently favor an Neutral trajectory for Incyte, with an average 1-year price target of $72.33, suggesting a potential 75.74% downside.</li>
</ul>
<h3>Comprehensive Peer Analysis Summary</h3>
<p>The peer analysis summary presents essential metrics for Neurocrine Biosciences, Moderna and Incyte, unveiling their respective standings within the industry and providing valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>United Therapeutics</td>
<td>Neutral</td>
<td>17.22%</td>
<td>$701.90M</td>
<td>4.86%</td>
</tr>
<tr>
<td>Neurocrine Biosciences</td>
<td>Buy</td>
<td>11.12%</td>
<td>$563.40M</td>
<td>0.31%</td>
</tr>
<tr>
<td>Moderna</td>
<td>Neutral</td>
<td>-35.93%</td>
<td>$17M</td>
<td>-9.26%</td>
</tr>
<tr>
<td>Incyte</td>
<td>Neutral</td>
<td>19.53%</td>
<td>$979.70M</td>
<td>4.45%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>United Therapeutics is positioned in the middle among its peers for consensus rating. It ranks at the bottom for revenue growth. In terms of gross profit, it is at the top. For return on equity, it is positioned in the middle.</p>
<h3>All You Need to Know About United Therapeutics</h3>
<p>United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. In addition, it is developing a pipeline of projects that includes new indications and delivery devices for existing products and new products to treat PAH and other conditions.</p>
<h3>United Therapeutics: A Financial Overview</h3>
<p><strong>Market Capitalization Analysis:</strong> Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.</p>
<p><strong>Revenue Growth:</strong> United Therapeutics's revenue growth over a period of 3 months has been noteworthy. As of 31 March, 2025, the company achieved a revenue growth rate of approximately <strong>17.22%</strong>. This indicates a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Health Care sector.</p>
<p><strong>Net Margin:</strong> United Therapeutics's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of <strong>40.56%,</strong> the company showcases strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> United Therapeutics's ROE stands out, surpassing industry averages. With an impressive ROE of <strong>4.86%</strong>, the company demonstrates effective use of equity capital and strong financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> United Therapeutics's ROA excels beyond industry benchmarks, reaching <strong>4.27%</strong>. This signifies efficient management of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at <strong>0.03</strong>.</p>
<p><a href="https://www.benzinga.com/quote/UTHR/earnings"><strong>To track all earnings releases for United Therapeutics visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


UTHR

Preview: United Therapeutics's Earnings

<p>Tradeweb Markets (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TW#NASDAQ">TW</a>) is gearing up to announce its quarterly earnings on Wednesday, 2025-07-30. Here's a quick overview of what investors should know before the release.</p>
<p>Analysts are estimating that Tradeweb Markets will report an <strong>earnings per share</strong> (EPS) of $0.86.</p>
<p>Tradeweb Markets bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Past Earnings Performance</h3>
<p>In the previous earnings release, the company missed EPS by $0.00, leading to a 0.17% drop in the share price the following trading session.</p>
<p>Here's a look at Tradeweb Markets's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.86</td>
<td>0.74</td>
<td>0.76</td>
<td>0.69</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.86</td>
<td>0.76</td>
<td>0.75</td>
<td>0.70</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-0.0%</td>
<td>1.0%</td>
<td>-1.0%</td>
<td>2.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1753804968_0.png" alt="eps graph" /></p>
<h3>Performance of Tradeweb Markets Shares</h3>
<p>Shares of Tradeweb Markets were trading at $137.8 as of July 28. Over the last 52-week period, shares are up 23.49%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release. </p>
<h3>Analyst Opinions on Tradeweb Markets</h3>
<p>Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Tradeweb Markets.</p>
<p>A total of 4 analyst ratings have been received for Tradeweb Markets, with the consensus rating being Outperform. The average one-year price target stands at $146.75, suggesting a potential 6.49% upside.</p>
<h3>Analyzing Ratings Among Peers</h3>
<p>In this analysis, we delve into the analyst ratings and average 1-year price targets of FactSet Research Systems, Morningstar and MarketAxess Holdings, three key industry players, offering insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Neutral trajectory for FactSet Research Systems, with an average 1-year price target of $450.67, suggesting a potential 227.05% upside.</li>
<li>Analysts currently favor an Outperform trajectory for Morningstar, with an average 1-year price target of $355.0, suggesting a potential 157.62% upside.</li>
<li>Analysts currently favor an Neutral trajectory for MarketAxess Holdings, with an average 1-year price target of $241.38, suggesting a potential 75.17% upside.</li>
</ul>
<h3>Overview of Peer Analysis</h3>
<p>Within the peer analysis summary, vital metrics for FactSet Research Systems, Morningstar and MarketAxess Holdings are presented, shedding light on their respective standings within the industry and offering valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Tradeweb Markets</td>
<td>Outperform</td>
<td>24.70%</td>
<td>$332.80M</td>
<td>2.53%</td>
</tr>
<tr>
<td>FactSet Research Systems</td>
<td>Neutral</td>
<td>5.94%</td>
<td>$304.79M</td>
<td>7.05%</td>
</tr>
<tr>
<td>Morningstar</td>
<td>Outperform</td>
<td>7.20%</td>
<td>$350.50M</td>
<td>4.86%</td>
</tr>
<tr>
<td>MarketAxess Holdings</td>
<td>Neutral</td>
<td>-0.83%</td>
<td>$142.47M</td>
<td>1.10%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Tradeweb Markets ranks highest in Revenue Growth among its peers. It also leads in Gross Profit. However, it has the lowest Return on Equity. Overall, Tradeweb Markets is positioned at the top compared to its peers in this analysis.</p>
<h3>About Tradeweb Markets</h3>
<p>Founded in 1998 and headquartered in New York City, Tradeweb Markets is a leading fixed-income trading platform. While it does offer electronic processing for some voice-negotiated trades, the company focuses primarily on providing electronic trading networks that connect broker/dealers, institutional clients, and retail customers. While the company offers trading in a wide variety of products, the bulk of its business is in U.S. and European government debt, mortgage-backed securities, interest-rate swaps, and U.S. and international corporate bonds. The firm also sells fixed-income trading and price data, primarily through a deal with Refinitiv's Eikon service.</p>
<h3>Tradeweb Markets's Economic Impact: An Analysis</h3>
<p><strong>Market Capitalization Analysis:</strong> Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.</p>
<p><strong>Revenue Growth:</strong> Over the 3 months period, Tradeweb Markets showcased positive performance, achieving a revenue growth rate of <strong>24.7%</strong> as of 31 March, 2025. This reflects a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Financials sector.</p>
<p><strong>Net Margin:</strong> Tradeweb Markets's net margin excels beyond industry benchmarks, reaching <strong>29.09%</strong>. This signifies efficient cost management and strong financial health.</p>
<p><strong>Return on Equity (ROE):</strong> Tradeweb Markets's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of <strong>2.53%,</strong> the company may face hurdles in achieving optimal financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> Tradeweb Markets's ROA stands out, surpassing industry averages. With an impressive ROA of <strong>2.03%</strong>, the company demonstrates effective utilization of assets and strong financial performance.</p>
<p><strong>Debt Management:</strong> Tradeweb Markets's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of <strong>0.01</strong>.</p>
<p><a href="https://www.benzinga.com/quote/TW/earnings"><strong>To track all earnings releases for Tradeweb Markets visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


A Preview Of Tradeweb Markets's Earnings

<p>PTC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTC#NASDAQ">PTC</a>) will release its quarterly earnings report on Wednesday, 2025-07-30. Here's a brief overview for investors ahead of the announcement.</p>
<p>Analysts anticipate PTC to report an <strong>earnings per share</strong> (EPS) of $1.09.</p>
<p>Anticipation surrounds PTC's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.</p>
<p>New investors should understand that while earnings performance is important, market reactions are often driven by guidance.</p>
<h3>Earnings Track Record</h3>
<p>The company's EPS beat by $0.39 in the last quarter, leading to a 0.88% increase in the share price on the following day.</p>
<p>Here's a look at PTC's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q2 2025</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.40</td>
<td>0.89</td>
<td>1.45</td>
<td>0.96</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.79</td>
<td>1.10</td>
<td>1.54</td>
<td>0.98</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>1.0%</td>
<td>-10.0%</td>
<td>-4.0%</td>
<td>-1.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1753804959_0.png" alt="eps graph" /></p>
<h3>Performance of PTC Shares</h3>
<p>Shares of PTC were trading at $204.0 as of July 28. Over the last 52-week period, shares are up 14.35%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<h3>Analyst Observations about PTC</h3>
<p>For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on PTC.</p>
<p>With 10 analyst ratings, PTC has a consensus rating of Outperform. The average one-year price target is $199.9, indicating a potential 2.01% downside.</p>
<h3>Comparing Ratings with Competitors</h3>
<p>This comparison focuses on the analyst ratings and average 1-year price targets of Tyler Technologies, Zoom Communications and Samsara, three major players in the industry, shedding light on their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Buy trajectory for Tyler Technologies, with an average 1-year price target of $675.0, suggesting a potential 230.88% upside.</li>
<li>Analysts currently favor an Neutral trajectory for Zoom Communications, with an average 1-year price target of $88.21, suggesting a potential 56.76% downside.</li>
<li>Analysts currently favor an Outperform trajectory for Samsara, with an average 1-year price target of $52.33, suggesting a potential 74.35% downside.</li>
</ul>
<h3>Overview of Peer Analysis</h3>
<p>The peer analysis summary provides a snapshot of key metrics for Tyler Technologies, Zoom Communications and Samsara, illuminating their respective standings within the industry. These metrics offer valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>PTC</td>
<td>Outperform</td>
<td>5.52%</td>
<td>$530.10M</td>
<td>4.92%</td>
</tr>
<tr>
<td>Tyler Technologies</td>
<td>Buy</td>
<td>10.31%</td>
<td>$267.08M</td>
<td>2.35%</td>
</tr>
<tr>
<td>Zoom Communications</td>
<td>Neutral</td>
<td>2.93%</td>
<td>$896.31M</td>
<td>2.85%</td>
</tr>
<tr>
<td>Samsara</td>
<td>Outperform</td>
<td>30.69%</td>
<td>$283.71M</td>
<td>-2.01%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>PTC ranks at the top for Gross Profit and Return on Equity among its peers. It is in the middle for Revenue Growth.</p>
<h3>About PTC</h3>
<p>PTC offers high-end computer-assisted design (Creo) and product lifecycle management (Windchill) software as well as Internet of Things and AR industrial solutions. Founded in 1985, PTC has 28,000 customers, with revenue stemming mostly from North America and Europe.</p>
<h3>Unraveling the Financial Story of PTC</h3>
<p><strong>Market Capitalization:</strong> With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.</p>
<p><strong>Revenue Growth:</strong> Over the 3 months period, PTC showcased positive performance, achieving a revenue growth rate of <strong>5.52%</strong> as of 31 March, 2025. This reflects a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Information Technology sector.</p>
<p><strong>Net Margin:</strong> PTC's net margin is impressive, surpassing industry averages. With a net margin of <strong>25.56%,</strong> the company demonstrates strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> PTC's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of <strong>4.92%,</strong> the company may face hurdles in achieving optimal financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> PTC's ROA excels beyond industry benchmarks, reaching <strong>2.66%</strong>. This signifies efficient management of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> PTC's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of <strong>0.46</strong>.</p>
<p><a href="https://www.benzinga.com/quote/PTC/earnings"><strong>To track all earnings releases for PTC visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Preview: PTC's Earnings

<p>Prudential Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRU#NYSE">PRU</a>) is preparing to release its quarterly earnings on Wednesday, 2025-07-30. Here's a brief overview of what investors should keep in mind before the announcement.</p>
<p>Analysts expect Prudential Financial to report an <strong>earnings per share</strong> (EPS) of $3.22.</p>
<p>The announcement from Prudential Financial is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.</p>
<p>It's worth noting for new investors that guidance can be a key determinant of stock price movements.</p>
<h3>Past Earnings Performance</h3>
<p>The company's EPS beat by $0.11 in the last quarter, leading to a 0.95% drop in the share price on the following day.</p>
<p>Here's a look at Prudential Financial's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>3.18</td>
<td>3.26</td>
<td>3.48</td>
<td>3.45</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>3.29</td>
<td>2.96</td>
<td>3.48</td>
<td>3.39</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-1.0%</td>
<td>-3.0%</td>
<td>-3.0%</td>
<td>-10.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1753804947_0.png" alt="eps graph" /></p>
<h3>Performance of Prudential Financial Shares</h3>
<p>Shares of Prudential Financial were trading at $103.75 as of July 28. Over the last 52-week period, shares are down 17.26%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/PRU/earnings"><strong>To track all earnings releases for Prudential Financial visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Insights into Prudential Financial's Upcoming Earnings

<p>Kraft Heinz (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KHC#NASDAQ">KHC</a>) will release its quarterly earnings report on Wednesday, 2025-07-30. Here's a brief overview for investors ahead of the announcement.</p>
<p>Analysts anticipate Kraft Heinz to report an <strong>earnings per share</strong> (EPS) of $0.64.</p>
<p>Investors in Kraft Heinz are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.</p>
<p>It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.</p>
<h3>Overview of Past Earnings</h3>
<p>The company's EPS beat by $0.02 in the last quarter, leading to a 0.8% increase in the share price on the following day.</p>
<p>Here's a look at Kraft Heinz's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.60</td>
<td>0.78</td>
<td>0.74</td>
<td>0.74</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.62</td>
<td>0.84</td>
<td>0.75</td>
<td>0.78</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>1.0%</td>
<td>2.0%</td>
<td>-1.0%</td>
<td>1.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1753804926_0.png" alt="eps graph" /></p>
<h3>Kraft Heinz Share Price Analysis</h3>
<p>Shares of Kraft Heinz were trading at $28.25 as of July 28. Over the last 52-week period, shares are down 18.83%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release. </p>
<h3>Analyst Observations about Kraft Heinz</h3>
<p>Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Kraft Heinz.</p>
<p>Analysts have provided Kraft Heinz with 7 ratings, resulting in a consensus rating of Neutral. The average one-year price target stands at $28.0, suggesting a potential 0.88% downside.</p>
<h3>Comparing Ratings Among Industry Peers</h3>
<p>The analysis below examines the analyst ratings and average 1-year price targets of Hershey, Kellanova and General Mills, three significant industry players, providing valuable insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Neutral trajectory for Hershey, with an average 1-year price target of $164.75, suggesting a potential 483.19% upside.</li>
<li>Analysts currently favor an Neutral trajectory for Kellanova, with an average 1-year price target of $83.5, suggesting a potential 195.58% upside.</li>
<li>Analysts currently favor an Neutral trajectory for General Mills, with an average 1-year price target of $55.33, suggesting a potential 95.86% upside.</li>
</ul>
<h3>Snapshot: Peer Analysis</h3>
<p>The peer analysis summary provides a snapshot of key metrics for Hershey, Kellanova and General Mills, illuminating their respective standings within the industry. These metrics offer valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Kraft Heinz</td>
<td>Neutral</td>
<td>-6.43%</td>
<td>$2.06B</td>
<td>1.44%</td>
</tr>
<tr>
<td>Hershey</td>
<td>Neutral</td>
<td>-13.75%</td>
<td>$944.27M</td>
<td>4.77%</td>
</tr>
<tr>
<td>Kellanova</td>
<td>Neutral</td>
<td>-3.66%</td>
<td>$1.06B</td>
<td>7.91%</td>
</tr>
<tr>
<td>General Mills</td>
<td>Neutral</td>
<td>-3.35%</td>
<td>$1.47B</td>
<td>3.07%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Kraft Heinz ranks in the middle for consensus rating. It is at the bottom for revenue growth. It is at the top for gross profit. It is at the bottom for return on equity.</p>
<h3>Delving into Kraft Heinz's Background</h3>
<p>In July 2015, Kraft merged with Heinz to create one of North America's largest food and beverage manufacturers. Beyond its namesake brands, its portfolio has since included Oscar Mayer, Velveeta, and Philadelphia. While the retail channel drives around 85% of its total sales, the firm also maintains a growing foodservice presence. Outside North America, Kraft Heinz's global reach includes a distribution network in Europe and emerging markets that drives nearly 25% of its consolidated sales base, as its products are sold in more than 190 countries and territories.</p>
<h3>Kraft Heinz's Economic Impact: An Analysis</h3>
<p><strong>Market Capitalization:</strong> Surpassing industry standards, the company's market capitalization asserts its dominance in terms of size, suggesting a robust market position.</p>
<p><strong>Negative Revenue Trend:</strong> Examining Kraft Heinz's financials over 3 months reveals challenges. As of 31 March, 2025, the company experienced a decline of approximately <strong>-6.43%</strong> in revenue growth, reflecting a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Consumer Staples sector.</p>
<p><strong>Net Margin:</strong> Kraft Heinz's net margin is impressive, surpassing industry averages. With a net margin of <strong>11.87%,</strong> the company demonstrates strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of <strong>1.44%,</strong> the company may need to address challenges in generating satisfactory returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of <strong>0.8%,</strong> the company may need to address challenges in generating satisfactory returns from its assets.</p>
<p><strong>Debt Management:</strong> With a below-average debt-to-equity ratio of <strong>0.44</strong>, Kraft Heinz adopts a prudent financial strategy, indicating a balanced approach to debt management.</p>
<p><a href="https://www.benzinga.com/quote/KHC/earnings"><strong>To track all earnings releases for Kraft Heinz visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Earnings Preview For Kraft Heinz

<p>JP Morgan  analyst Brian Ossenbeck   maintains TFI International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TFII#NYSE">TFII</a>) with a Overweight and raises the price target from $101 to $116.</p>


TFII

JP Morgan Maintains Overweight on TFI International, Raises Price Target to $116

<p><strong>Hershey</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HSY#NYSE">HSY</a>) is set to give its latest quarterly earnings report on Wednesday, 2025-07-30. Here's what investors need to know before the announcement.</p>
<p>Analysts estimate that Hershey will report an <strong>earnings per share</strong> (EPS) of $1.01. </p>
<p>Anticipation surrounds Hershey's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.</p>
<p>New investors should understand that while earnings performance is important, market reactions are often driven by guidance.</p>
<h3>Past Earnings Performance</h3>
<p>During the last quarter, the company reported an EPS beat by $0.14, leading to a 2.26% drop in the share price on the subsequent day.</p>
<p>Here's a look at Hershey's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.95</td>
<td>2.38</td>
<td>2.56</td>
<td>1.44</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>2.09</td>
<td>2.69</td>
<td>2.34</td>
<td>1.27</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-2.0%</td>
<td>2.0%</td>
<td>2.0%</td>
<td>-0.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1753804914_0.png" alt="eps graph" /></p>
<h3>Stock Performance</h3>
<p>Shares of Hershey were trading at $184.56 as of July 28. Over the last 52-week period, shares are down 5.47%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release. </p>
<h3>Analysts' Perspectives on Hershey</h3>
<p>For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Hershey.</p>
<p>Hershey has received a total of 8 ratings from analysts, with the consensus rating as Neutral. With an average one-year price target of $164.75, the consensus suggests a potential 10.73% downside.</p>
<h3>Comparing Ratings Among Industry Peers</h3>
<p>The below comparison of the analyst ratings and average 1-year price targets of Kraft Heinz, Kellanova and General Mills, three prominent players in the industry, gives insights for their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Neutral trajectory for Kraft Heinz, with an average 1-year price target of $28.0, suggesting a potential 84.83% downside.</li>
<li>Analysts currently favor an Neutral trajectory for Kellanova, with an average 1-year price target of $83.5, suggesting a potential 54.76% downside.</li>
<li>Analysts currently favor an Neutral trajectory for General Mills, with an average 1-year price target of $55.33, suggesting a potential 70.02% downside.</li>
</ul>
<h3>Analysis Summary for Peers</h3>
<p>Within the peer analysis summary, vital metrics for Kraft Heinz, Kellanova and General Mills are presented, shedding light on their respective standings within the industry and offering valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Hershey</td>
<td>Neutral</td>
<td>-13.75%</td>
<td>$944.27M</td>
<td>4.77%</td>
</tr>
<tr>
<td>Kraft Heinz</td>
<td>Neutral</td>
<td>-6.43%</td>
<td>$2.06B</td>
<td>1.44%</td>
</tr>
<tr>
<td>Kellanova</td>
<td>Neutral</td>
<td>-3.66%</td>
<td>$1.06B</td>
<td>7.91%</td>
</tr>
<tr>
<td>General Mills</td>
<td>Neutral</td>
<td>-3.35%</td>
<td>$1.47B</td>
<td>3.07%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Hershey ranks at the top for Gross Profit and Return on Equity among its peers. However, it ranks at the bottom for Revenue Growth.</p>
<h3>Discovering Hershey: A Closer Look</h3>
<p>Hershey is a leading US confectionery manufacturer (around a $54 billion market, according to Euromonitor), controlling around 36% of the domestic chocolate space. Beyond its namesake label, the firm's mix has expanded over the last 85 years and now consists of 100 brands, including Reese's, Kit Kat, Kisses, and Ice Breakers. Hershey's products are sold in about 80 countries, albeit with just a high-single-digit percentage of sales coming from markets outside the US, including Brazil, India, and Mexico. The firm has sought inorganic opportunities to extend its reach beyond its core confection business, adding Amplify Snack Brands and its Skinny Pop ready-to-eat popcorn to its mix, Pirate Brands, and Dot's Pretzels over the past few years.</p>
<h3>Hershey: A Financial Overview</h3>
<p><strong>Market Capitalization Analysis:</strong> With a profound presence, the company's market capitalization is above industry averages. This reflects substantial size and strong market recognition.</p>
<p><strong>Negative Revenue Trend:</strong> Examining Hershey's financials over 3 months reveals challenges. As of 31 March, 2025, the company experienced a decline of approximately <strong>-13.75%</strong> in revenue growth, reflecting a decrease in top-line earnings. When compared to others in the Consumer Staples sector, the company faces challenges, achieving a growth rate lower than the average among peers.</p>
<p><strong>Net Margin:</strong> Hershey's net margin is impressive, surpassing industry averages. With a net margin of <strong>7.99%,</strong> the company demonstrates strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Hershey's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>4.77%</strong> ROE, the company effectively utilizes shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of <strong>1.67%,</strong> the company showcases effective utilization of assets.</p>
<p><strong>Debt Management:</strong> Hershey's debt-to-equity ratio surpasses industry norms, standing at <strong>1.34</strong>. This suggests the company carries a substantial amount of debt, posing potential financial challenges.</p>
<p><a href="https://www.benzinga.com/quote/HSY/earnings"><strong>To track all earnings releases for Hershey visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


A Look Ahead: Hershey's Earnings Forecast

<p><strong>FirstEnergy</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FE#NYSE">FE</a>) is set to give its latest quarterly earnings report on Wednesday, 2025-07-30. Here's what investors need to know before the announcement.</p>
<p>Analysts estimate that FirstEnergy will report an <strong>earnings per share</strong> (EPS) of $0.50. </p>
<p>Anticipation surrounds FirstEnergy's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.</p>
<p>New investors should understand that while earnings performance is important, market reactions are often driven by guidance.</p>
<h3>Overview of Past Earnings</h3>
<p>In the previous earnings release, the company beat EPS by $0.08, leading to a 0.68% drop in the share price the following trading session.</p>
<p>Here's a look at FirstEnergy's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.59</td>
<td>0.70</td>
<td>0.90</td>
<td>0.56</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.67</td>
<td>0.67</td>
<td>0.85</td>
<td>0.56</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-1.0%</td>
<td>-10.0%</td>
<td>-2.0%</td>
<td>0.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1753804900_0.png" alt="eps graph" /></p>
<h3>Tracking FirstEnergy's Stock Performance</h3>
<p>Shares of FirstEnergy were trading at $41.41 as of July 28. Over the last 52-week period, shares are down 0.32%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release. </p>
<h3>Analysts' Perspectives on FirstEnergy</h3>
<p>For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding FirstEnergy.</p>
<p>With 4 analyst ratings, FirstEnergy has a consensus rating of Outperform. The average one-year price target is $46.25, indicating a potential 11.69% upside.</p>
<h3>Understanding Analyst Ratings Among Peers</h3>
<p>In this comparison, we explore the analyst ratings and average 1-year price targets of Eversource Energy, PPL and Edison Intl, three prominent industry players, offering insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Neutral trajectory for Eversource Energy, with an average 1-year price target of $69.5, suggesting a potential 67.83% upside.</li>
<li>Analysts currently favor an Buy trajectory for PPL, with an average 1-year price target of $37.33, suggesting a potential 9.85% downside.</li>
<li>Analysts currently favor an Underperform trajectory for Edison Intl, with an average 1-year price target of $60.25, suggesting a potential 45.5% upside.</li>
</ul>
<h3>Peer Analysis Summary</h3>
<p>The peer analysis summary outlines pivotal metrics for Eversource Energy, PPL and Edison Intl, demonstrating their respective standings within the industry and offering valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>FirstEnergy</td>
<td>Outperform</td>
<td>14.54%</td>
<td>$2.53B</td>
<td>2.88%</td>
</tr>
<tr>
<td>Eversource Energy</td>
<td>Neutral</td>
<td>23.58%</td>
<td>$2.29B</td>
<td>3.63%</td>
</tr>
<tr>
<td>PPL</td>
<td>Buy</td>
<td>8.68%</td>
<td>$1.11B</td>
<td>2.91%</td>
</tr>
<tr>
<td>Edison Intl</td>
<td>Underperform</td>
<td>-6.55%</td>
<td>$1.78B</td>
<td>9.94%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>FirstEnergy ranks first in revenue growth among its peers. It has the highest gross profit and the lowest return on equity.</p>
<h3>Get to Know FirstEnergy Better</h3>
<p>FirstEnergy is an investor-owned holding company with 10 regulated distribution utilities across six mid-Atlantic and Midwestern states. FirstEnergy also owns and operates one of the nation's largest electric transmission systems.</p>
<h3>Unraveling the Financial Story of FirstEnergy</h3>
<p><strong>Market Capitalization Analysis:</strong> Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.</p>
<p><strong>Revenue Growth:</strong> FirstEnergy's revenue growth over a period of 3 months has been noteworthy. As of 31 March, 2025, the company achieved a revenue growth rate of approximately <strong>14.54%</strong>. This indicates a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Utilities sector.</p>
<p><strong>Net Margin:</strong> FirstEnergy's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of <strong>9.56%,</strong> the company may face hurdles in effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> FirstEnergy's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of <strong>2.88%,</strong> the company may face hurdles in generating optimal returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> FirstEnergy's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of <strong>0.69%,</strong> the company may face hurdles in achieving optimal financial returns.</p>
<p><strong>Debt Management:</strong> The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of <strong>1.97</strong>, caution is advised due to increased financial risk.</p>
<p><a href="https://www.benzinga.com/quote/FE/earnings"><strong>To track all earnings releases for FirstEnergy visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Earnings Preview For FirstEnergy

<p>Entergy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ETR#NYSE">ETR</a>) is preparing to release its quarterly earnings on Wednesday, 2025-07-30. Here's a brief overview of what investors should keep in mind before the announcement.</p>
<p>Analysts expect Entergy to report an <strong>earnings per share</strong> (EPS) of $0.91.</p>
<p>Entergy bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Historical Earnings Performance</h3>
<p>During the last quarter, the company reported an EPS beat by $0.13, leading to a 0.43% drop in the share price on the subsequent day.</p>
<p>Here's a look at Entergy's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.69</td>
<td>0.64</td>
<td>1.49</td>
<td>0.88</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.82</td>
<td>0.66</td>
<td>1.50</td>
<td>0.96</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-0.0%</td>
<td>-0.0%</td>
<td>-6.0%</td>
<td>-0.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1753804886_0.png" alt="eps graph" /></p>
<h3>Stock Performance</h3>
<p>Shares of Entergy were trading at $86.68 as of July 28. Over the last 52-week period, shares are up 52.27%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<h3>Analyst Insights on Entergy</h3>
<p>For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Entergy.</p>
<p>A total of 7 analyst ratings have been received for Entergy, with the consensus rating being Outperform. The average one-year price target stands at $89.57, suggesting a potential 3.33% upside.</p>
<h3>Peer Ratings Comparison</h3>
<p>The following analysis focuses on the analyst ratings and average 1-year price targets of Xcel Energy, Exelon and NRG Energy, three prominent industry players, providing insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Neutral trajectory for Xcel Energy, with an average 1-year price target of $77.5, suggesting a potential 10.59% downside.</li>
<li>Analysts currently favor an Neutral trajectory for Exelon, with an average 1-year price target of $46.38, suggesting a potential 46.49% downside.</li>
<li>Analysts currently favor an Buy trajectory for NRG Energy, with an average 1-year price target of $178.43, suggesting a potential 105.85% upside.</li>
</ul>
<h3>Summary of Peers Analysis</h3>
<p>The peer analysis summary presents essential metrics for Xcel Energy, Exelon and NRG Energy, unveiling their respective standings within the industry and providing valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Entergy</td>
<td>Outperform</td>
<td>1.87%</td>
<td>$1.45B</td>
<td>2.38%</td>
</tr>
<tr>
<td>Xcel Energy</td>
<td>Neutral</td>
<td>7.04%</td>
<td>$1.69B</td>
<td>2.46%</td>
</tr>
<tr>
<td>Exelon</td>
<td>Neutral</td>
<td>11.10%</td>
<td>$2.85B</td>
<td>3.33%</td>
</tr>
<tr>
<td>NRG Energy</td>
<td>Buy</td>
<td>15.56%</td>
<td>$2.02B</td>
<td>37.07%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Entergy ranks at the bottom for Revenue Growth among its peers. It is in the middle for Gross Profit. For Return on Equity, Entergy is at the bottom compared to its peers.</p>
<h3>Get to Know Entergy Better</h3>
<p>Entergy is a holding company with five regulated integrated utilities that generate and distribute electricity to about 3 million customers in Arkansas, Louisiana, Mississippi, and Texas. It is one of the largest power producers in the country with 24 gigawatts of rate-regulated owned and leased power generation capacity. Entergy was the second-largest nuclear owner in the US before it began retiring and selling its plants in the Northeast in 2014. It plans to sell its two small gas utilities in Louisiana.</p>
<h3>Entergy: Financial Performance Dissected</h3>
<p><strong>Market Capitalization Analysis:</strong> With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.</p>
<p><strong>Positive Revenue Trend:</strong> Examining Entergy's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of <strong>1.87%</strong> as of 31 March, 2025, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Utilities sector.</p>
<p><strong>Net Margin:</strong> Entergy's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>12.67%</strong> net margin, the company effectively manages costs and achieves strong profitability.</p>
<p><strong>Return on Equity (ROE):</strong> Entergy's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of <strong>2.38%,</strong> the company may face hurdles in achieving optimal financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> Entergy's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of <strong>0.55%,</strong> the company may face hurdles in achieving optimal financial performance.</p>
<p><strong>Debt Management:</strong> The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of <strong>2.04</strong>, caution is advised due to increased financial risk.</p>
<p><a href="https://www.benzinga.com/quote/ETR/earnings"><strong>To track all earnings releases for Entergy visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Insights into Entergy's Upcoming Earnings

<p>JP Morgan  analyst Michael Rehaut   maintains Mohawk Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MHK#NYSE">MHK</a>) with a Overweight and raises the price target from $139 to $140.</p>


JP Morgan Maintains Overweight on Mohawk Industries, Raises Price Target to $140

<p>Everest Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EG#NYSE">EG</a>) is preparing to release its quarterly earnings on Wednesday, 2025-07-30. Here's a brief overview of what investors should keep in mind before the announcement.</p>
<p>Analysts expect Everest Group to report an <strong>earnings per share</strong> (EPS) of $14.95.</p>
<p>Anticipation surrounds Everest Group's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.</p>
<p>New investors should understand that while earnings performance is important, market reactions are often driven by guidance.</p>
<h3>Overview of Past Earnings</h3>
<p>Last quarter the company missed EPS by $1.17, which was followed by a 5.98% drop in the share price the next day.</p>
<p>Here's a look at Everest Group's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>7.62</td>
<td>-17.42</td>
<td>11.91</td>
<td>16.59</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>6.45</td>
<td>-18.39</td>
<td>14.62</td>
<td>16.85</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-6.0%</td>
<td>-1.0%</td>
<td>-6.0%</td>
<td>-6.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1753804872_0.png" alt="eps graph" /></p>
<h3>Stock Performance</h3>
<p>Shares of Everest Group were trading at $331.35 as of July 28. Over the last 52-week period, shares are down 14.89%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/EG/earnings"><strong>To track all earnings releases for Everest Group visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


A Look at Everest Group's Upcoming Earnings Report

<p>Turns out, a $17-an-hour paycheck doesn't go as far as it used to—especially if you're young, exhausted, and juggling two jobs just to survive.&nbsp;</p>
<p>Ford (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>) CEO<strong> Jim Farley</strong> heard this loud and clear from his own factory floors. And instead of shrugging it off or blaming "kids these days," he made a move that echoed the bold playbook of Henry Ford himself—one that he says America desperately needs more of.</p>
<p>In a June <a href="https://youtu.be/zIUfbpK3yBQ?si=6wCMDBNHBKz8YrvJ">interview at the Aspen Ideas Festival</a> with <strong>Walter Isaacson</strong>—the renowned biographer best known for his books on <strong>Steve Jobs</strong>, <strong>Leonardo da Vinci</strong>, and <strong>Elon Musk</strong>—Farley peeled back the curtain on what younger workers were really telling him about life on a $17 wage.</p>
<p><strong>Don't Miss:</strong></p>
<ul class="wp-block-list">
<li><strong>7,000+ investors have joined Timeplast's mission to eliminate microplastics—now it's your turn to <a href="https://www.benzinga.com/money/timeplast-advertorial"><strong>invest in the future of sustainable plastic before time runs out.</strong></a></strong></li>
<li><strong>$100k+ in investable assets? <a href="https://www.benzinga.com/money/wiseradvisor-retirement-planning"><strong>Match with a fiduciary advisor for free to learn how you can maximize your retirement and save on taxes</strong></a> – no cost, no obligation.</strong></li>
</ul>
<p>"The older workers who'd been at the company said, ‘None of the young people want to work here. Jim, you pay $17 an hour, and they are so stressed,'" Farley recalled. "They've got to work at Amazon for eight hours, then they come over to Ford for seven hours, and then they sleep for three or four hours—and then they go back. And they're barely getting by."</p>
<p>Rather than issue a tone-deaf memo or wait for another generation to settle for less, Farley made a decisive, expensive change: he converted every temporary worker into a full-time employee.</p>
<p>"It wasn't easy to do," he admitted. "It was expensive. But I think that's the kind of changes we need to make in our country."</p>
<p>Farley's move isn't just about better paychecks—it's about reviving an old-school idea that once turned Ford into a powerhouse: <a href="https://www.benzinga.com/news/politics/25/06/45877457/josh-hawley-peter-welch-propose-raising-federal-minimum-wage-to-15-by-2026-tied-to-inflation">when you pay workers well</a>, they can afford the products they help build.</p>
<p><strong>Trending: ‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. You can <a href="https://www.benzinga.com/money/mode-mobile-2"><strong>invest today for just $0.30/share.</strong></a></strong></p>
<p>Quoting the legendary <strong>Henry Ford</strong>, Farley said, "‘I'm doing this because I want my factory worker to buy my cars. If they make enough money, they'll buy my own product.'" Then he added, "It's a self-fulfilling prophecy, in a way."</p>
<p>In 1914, <strong>Henry Ford</strong> <a href="https://www.cbsnews.com/detroit/news/henry-ford-implements-5-per-day-wage-this-day-in-history/">famously raised factory wages</a> to $5 a day—nearly double the going rate. It wasn't a random act of generosity. It was a smart bet that higher wages would lead to a more stable, productive workforce and—bonus—more people who could afford to drive off in a Model T. According to Farley, it worked then, and it can work now.</p>
<p>He also pointed to deeper structural issues. For Farley, the wage issue is just one layer of a bigger challenge: the U.S. hasn't kept up in preparing young people for <a href="https://www.benzinga.com/25/04/44881768/nearly-4-million-manufacturing-jobs-are-opening-as-boomers-retirebut-gen-z-is-not-interested">careers in skilled trades</a>.</p>
<p>"Our governments have to get really serious about investing in trade schools and skilled trades," Farley said. "You go to Germany—every one of our factory workers has an apprentice starting in junior high school. Every one of those jobs has a person behind it for eight years that is trained."</p>
<p><strong><em>See Also: Accredited Investors: Grab Pre-IPO Shares of the AI Company Powering Hasbro, Sephora &amp; MGM—<a href="https://www.benzinga.com/money/rad-intel"><strong><em>Just $0.63 Before NASDAQ Launch</em></strong></a></em></strong></p>
<p>Farley's big bet may not please Wall Street, but it's not aimed at them.</p>
<p>"We decided as a company that a cooler problem than full autonomy in an urban setting was high-speed, eyes-off driving on highways—push a button, read a book," he told Isaacson, in reference to how Ford picks its battles.</p>
<p>When it comes to labor, he's taking that same eyes-on-the-road approach—focusing on people, not just profits. And while turning temps into full-timers might not boost short-term stock prices, Farley's betting on a longer game: one where the people building America's cars can actually afford to drive them.</p>
<p><strong>Read Next: Warren Buffett once said, "If you don't find a way to make money while you sleep, you will work until you die."<a href="https://www.benzinga.com/money/warren-buffet-make-money-when-you-sleep"><strong> </strong><strong>Here&#8217;s how you can earn passive income with just $10.</strong></a></strong></p>
<p><em><strong>Image: Shutterstock</strong></em></p>


Personal Finance

Ford CEO Found Young People Didn't Want to Work There Because $17 Wages Left Them 'So Stressed' - Then He Made An Expensive Change 'The Country Needs'

Press Releases

Pioneering precision: GE HealthCare aims to elevate clinical care through total body PET/CT technology with Stanford Medicine

Small Cap

Opinion

AI Tools That Talk, Scan, and Save Lives Are Reshaping the Investment Landscape

GE HealthCare drives innovation in theranostics with latest technological advances

GE HealthCare enhances cardiac diagnostics with innovative molecular imaging solutions showcased at SNMMI 2025

FDA Approves Expanded Indications for GE HealthCare's Vizamyl PET Imaging Agent for Beta Amyloid Detection, Enabling More Precise Care for Alzheimer's Patients

Comments

GE HealthCare Techs

Actualités

Dernières nouvelles pour GE HealthCare Techs (NASDAQ:GEHC) Stock

Les gens regardent aussi

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL